Oct
2026
Fiera Milano, Italy
Visit us
stand 7D58, Integrated Pharma

ST PHARM

Exhibitor at CPHI Milan 2026
About Us

ST Pharm has been offering excellent custom manufacturing services of oligonucleotides and small molecule APIs CDMO to meet clients’ high expectation for their use in pharmaceutical development in compliance to cGMP requirements. The expansion of oligonucleotide production capabilities became a new growth engine for the future pharmaceutical industry. Based on the in-depth knowledge from manufacturing nucleoside to oligonucleotide, it has enabled ST Pharm to leverage its know-how into manufacturing polynucleotide, the mRNA. STLNP®, 5' capping reagent (SmartCap®), Phosphoramidite

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 7D58, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Generic / Monomer

    Product Generic / Monomer

    1. Generic ST Pharm focusing on technical challenging and brand generics. We specialize in MRI contrast agents and and possess a portfolio of tuberculosis and anti-infectious drugs as generic APIs. 2. Monomer ST Pharm offers a one-stop service from nucleosides to phosphoramidites with specialty and commo...
  • mRNA CDMO

    Product mRNA CDMO

    ST Pharm provides mRNA CDMO service from custom mRNA IVT synthesis to lipid nanoparticle (LNP) formulation with its own IP on two key mRNA platform technologies, SmartCap (proprietary 5'-capping) and STLNP (LNP with novel ionizable lipid). We are able to manufacture in GMP/non-GMP grade, and able to suppo...
  • mRNA Platform Technology - SmartCap / STLNP

    Product mRNA Platform Technology - SmartCap / STLNP

  • Oligonucleotide CDMO

    Product Oligonucleotide CDMO

    ST Pharm offers top-tier customized oligonucleotide CDMO services under stringent cGMP conditions. We enhance raw material supply chain resilience by leveraging in-house manufacturing capabilities of nucleosides/phosphormaidites. Our two state-of-the-art facilities, expected to reach a 7.0 mol capacity b...
  • Small Molecule CDMO

    Product Small Molecule CDMO

    ST Pharm has a strong track record in small molecule CDMO services with over 30 years of experience. We came from a history of being the wolrd largest supplier of Thymidine (DT) to GSK and BMS and 1st HIV/AIDS drug (Zidovudine) to GSK. Over 20 small molecule programs up and running through two manufacturi...

ST Pharm Co. Ltd Resources (1)

  • ST Pharm Coporate Video (Company introduction)

    Video ST Pharm Coporate Video (Company introduction)

    ST Pharm, we are the innovative company saving lives. As a reliable CDMO partner, ST Pharm offers comprehensive contract development and manufacturing services. As your trusted partner, we will take you on a journey to explore the core values and capabilities that define our company.
    2023-07-28